KEPHAS PHARMA
ActiveSummary
KEPHAS PHARMA has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €33,505 and a net result of €7,346. Its solvency ranks better than 71% of 26,023 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 1.4% (low).
History
Acts, filings and financial milestones
2025
29-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
05-12
NBB filing
Annual accounts filed
financial year 2023 · micro format · 127 days late
NBB filing
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.